Citizen Health

Citizen Health provides an AI-driven digital health platform that aggregates patient medical records—including clinical data, genetic information, imaging, and patient-reported outcomes—to empower patients with rare or complex conditions. The platform facilitates real-world evidence generation for researchers and accelerates the development of therapies by enabling access to high-quality longitudinal datasets. It has established strategic partnerships with organizations like the Chan Zuckerberg Initiative’s Rare As One Project and Critical Path Institute to support regulatory-grade analysis in neuromuscular disorders. The company does not develop drugs itself but plays a critical role in supporting drug development through its technology.